Omnicell, Inc. ( OMCL ) NASDAQ Global Select

Cena: 33.51 ( 5.08% )

Aktualizacja 08-22 21:58
NASDAQ Global Select
Branża: Medical - Healthcare Information Services
Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

Notowania:

Opis firmy:

Omnicell, Inc., wraz ze swoimi spółkami zależnymi, zapewnia rozwiązania w zakresie zarządzania lekarstwami i narzędzia przylegające do systemów opieki zdrowotnej i apteki Stany Zjednoczone i na arenie międzynarodowej. Firma oferuje rozwiązania dotyczące automatyzacji opieki w celu poprawy przepływów pracy klinicysty w obszarach opieki nad pacjentem w systemie opieki zdrowotnej; Seria serii XT zautomatyzowane systemy dozowania leków i materiałów eksploatowanych w jednostkach pielęgniarskich i innych obszarach klinicznych szpitala, a także specjalistyczne zautomatyzowane systemy dozowania na sali operacyjnej; Oprogramowanie interfejsu Omnicell, które oferuje interfejs i integrację między produktami lub produktami zaopatrzenia w leki oraz wewnętrzne systemy zarządzania informacjami informacyjnymi; oraz robotyczne systemy dozowania do obsługi pończoch i pobierania leków pudełkowych. Zapewnia również środkowe rozwiązania do automatyzacji apteki, w tym zautomatyzowane systemy przechowywania i pobierania, takie jak zautomatyzowany system apteki centralnej XR2; IV złożone roboty i systemy zarządzania przepływem pracy; Oprogramowanie do zarządzania zapasami; i kontrolowane systemy zarządzania substancjami. Ponadto firma dostarcza rozwiązania automatyzacji jednomiedzy, które wypełniają i oznaczają różnorodne opakowanie w zakresie blistra z pojedynczymi dawkami, oparte na nadchodzących receptach; W pełni zautomatyzowany i półautomowany sprzęt do napełniania dla aptek instytucjonalnych w celu uzasadnienia zautomatyzowanego opakowania leków; oraz leki opakowanie kart i zapasy opakowania w celu zwiększenia przestrzegania leków w warunkach opieki bezwrotnej. Ponadto oferuje zaangażowanie pacjentów z OverrivenHealth, internetowym związkiem rozwiązań. Firma była wcześniej znana jako Omnicell Technologies, Inc. i zmieniła nazwę na Omnicell, Inc. w 2001 r. Omnicell, Inc. została zarejestrowana w 1992 roku i ma siedzibę w Mountain View w Kalifornii.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Healthcare Information Services
Zatrudnienie: 3 660
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 98.0893
Ilość akcji: Brak danych
Debiut giełdowy: 2001-08-09
WWW: https://www.omnicell.com
CEO: Mr. Randall A. Lipps
Adres: 590 East Middlefield Road
Siedziba: 94043 Mountain View
ISIN: US68213N1090
Wskaźniki finansowe
Kapitalizacja (USD) 1 539 255 042
Aktywa: 2 120 960 000
Cena: 33.51
Wskaźnik Altman Z-Score: 2.0
Umiarkowany (ryzyko bankructwa średnie)
Dywidenda: 0
P/E: 67.0
Ilość akcji w obrocie: 98%
Średni wolumen: 535 751
Ilość akcji 45 934 200
Wskaźniki finansowe
Przychody TTM 1 112 238 000
Zobowiązania: 877 647 000
Przedział 52 tyg.: 22.66 - 55.75
Piotroski F-Score: 6
Umiarkowany (średnia jakość finansowa)
EPS: 0.5
P/E branży: 35.1
Beta: 0.815
Raport okresowy: 2025-10-29
WWW: https://www.omnicell.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Corey J. Manley Executive Vice President, Chief Legal & Administrative Officer and Corporate Secretary 715 326 1978
Mr. Nchacha E. Etta Executive Vice President & Chief Financial Officer 480 215 1972
Mr. Randall A. Lipps Founder, Executive Chairman, President & Chief Executive Officer 1 847 202 1957
Mr. David J. Vanella Senior Vice President of Quality & Product Regulatory 0 0
Mr. Brian H. Nutt Vice President, Chief Accounting Officer & Corporate Controller 0 1970
Mr. Maximo Rocha Senior Vice President & Chief People Officer 0 0
Ms. Sara Dalmasso Senior Vice President & GM of International 0 0
Ms. Minoo Mortazavi Senior Vice President of Global Operations 0 0
Mr. Giri Chodavarapu Senior Vice President & Chief Information Officer 0 0
Ms. Kathleen Nemeth Senior Vice President of Investor Relations 0 0
Lista ETF z ekspozycją na akcje Omnicell, Inc.
Symbol ETF Ilość akcji Wartość
IJR 2 685 512 83 277 730
VB 1 086 898 31 954 801
IWM 1 071 865 33 238 547
VBR 693 823 20 398 396
BOTZ 528 112 16 376 753
IJS 422 353 13 097 165
SPSM 409 119 12 180 933
IWN 391 719 12 147 210
ROBO 338 741 18 617 205
SLYV 267 877 8 059 029
VTWO 237 315 6 977 061
DFAT 233 753 7 248 680
IHI 225 964 7 007 150
SCHA 220 573 6 482 977
KOMP 199 478 5 939 220
FESM 194 869 5 651 201
CALF 194 006 6 016 126
DFSV 179 907 5 578 916
FNDA 157 672 4 624 937
VIOO 155 084 4 559 469
VHT 146 407 4 304 365
DFAS 128 373 3 980 846
XHE 95 204 2 916 834
VIOV 94 710 2 784 474
AVSC 89 852 2 668 604
PRFZ 86 801 2 577 989
R2SC.L 72 428 1 630 090
R2US.L 72 428 2 151 111
ZPRR.DE 72 428 1 883 728
USVM 70 610 2 189 616
ROBT 70 366 1 988 543
ISP6.L 63 732 1 495 842
IDP6.L 63 732 1 976 327
IUS3.DE 63 732 1 728 890
NUSC 55 315 2 203 196
ITOT 51 702 1 603 265
PSCH 44 912 1 333 886
FSMD 41 734 1 210 286
RWJ 40 219 1 194 504
DFAC 37 668 1 168 084
FYX 34 899 986 245
IUSN.DE 32 459 880 541
WSML.L 32 459 1 006 562
WLDS.L 32 459 761 847
PSC 32 103 995 514
ESML 31 358 931 332
CSUSS.MI 31 021 841 516
CUS1.L 31 021 728 083
CUSS.L 31 021 961 953
SXRG.DE 31 021 841 516
VTWV 30 749 904 020
JPSE 26 777 830 354
SCHB 26 432 782 073
XRS2.DE 25 497 692 392
XRSU.L 25 497 790 673
XRSG.L 25 497 59 916 439
RSSL 23 752 736 549
ONEQ 22 336 647 744
DFUV 22 313 691 926
EDOC 21 608 756 496
JMEE 21 004 651 334
FHLC 19 615 568 835
IJR.AX 16 579 762 118
GOAI.PA 16 207 413 623
GOAI.DE 16 207 413 623
GOAI.MI 16 207 413 623
BBSC 15 574 482 949
EES 14 732 456 839
ISMD 13 587 421 332
HTEC 12 794 0
VFMO 12 453 366 118
WSCR.L 11 998 355 367
IWV 10 999 341 074
FYT 10 769 304 331
ESGV 9 890 290 766
DFAU 9 797 303 804
VFMF 9 043 265 864
GSSC 8 311 248 831
XSU.TO 8 048 330 125
QVMS 7 520 223 344
SPTM 7 134 212 188
AVUS 7 057 209 592
ZPRV.DE 6 783 153 670
USSC.L 6 783 175 483
UMDV.AS 6 096 189 040
SIXS 5 060 0
UWM 4 716 146 243
TILT 4 312 133 715
DFSU 4 062 125 962
DCOR 3 963 122 892
SIXL 3 943 0
URTY 3 903 121 032
XJR 3 710 110 187
VTHR 3 663 107 692
FDHT 3 632 105 328
OMFS 3 411 101 306
SQLV 3 120 92 664
AFSM 2 540 71 780
FAB 2 059 58 187
CBUG.DE 2 033 55 158
EWSA.AS 2 033 63 053
ISCB 1 909 59 192
XUU.TO 1 898 77 846
XSMC.TO 1 655 67 869
XSMH.TO 1 530 62 778
QQQS 1 231 36 560
FNDB 1 188 35 050
DXUV 1 116 34 607
SAA 864 26 792
VLU 819 24 461
CSA 590 17 652
V3AA.L 367 10 789
V3AB.L 367 8 176
V3AL.L 367 10 789
ESIX 357 10 663
XBAL.TO 312 12 791
XUH.TO 280 8 321
SCDS 249 7 721
CSF 184 5 505
HDG 56 1 736
XTR.TO 11 336
MMTM 7 207
SC0K.DE 0 120 303
USML.L 0 175 675
PZW.TO 0 12 071
USFM.L 0 0
RTYS.L 0 137 301
USUE.DE 0 0
Wiadomości dla Omnicell, Inc.
Tytuł Treść Źródło Aktualizacja Link
Omnicell's New Perioperative Clinic Setting Products May Boost Stock OMCL unveils new offerings for the perioperative and clinic setting. zacks.com 2025-05-15 13:56:04 Czytaj oryginał (ang.)
Omnicell Announces New Products for Perioperative and Clinic Settings FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces New Products for Perioperative and Clinic Settings. businesswire.com 2025-05-14 20:01:00 Czytaj oryginał (ang.)
Omnicell Opens New Innovation Lab in Austin, Texas AUSTIN, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced the opening of its Innovation Lab, located at 1005 East St. Elmo Road in Austin, Texas. The facility will serve as a hub focused on addressing challenges along the medication and supply journey and developing new technologies that are designed to solve evolving challenges faced by the healthcare industry. As hospitals. businesswire.com 2025-05-14 12:30:00 Czytaj oryginał (ang.)
Omnicell: Facing New Headwinds Omnicell, Inc., a small cap medical technology solutions provider, posted its Q1 results Tuesday.  Both top and the bottom-line results beat the consensus. However, thanks to some new headlines and reduced forward guidance, OMCL shares sold off 15% in trading yesterday. A buying opportunity?  An analysis around Omnicell follows in the paragraphs below. seekingalpha.com 2025-05-07 17:25:52 Czytaj oryginał (ang.)
Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up OMCL posts better-than-expected top and bottom-line results for the first quarter of 2025. zacks.com 2025-05-07 14:21:07 Czytaj oryginał (ang.)
Omnicell, Inc. (OMCL) Q1 2025 Earnings Conference Call Transcript Omnicell, Inc. (NASDAQ:OMCL ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - SVP, IR Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - EVP and CFO Nnamdi Njoku - COO Conference Call Participants Jessica Datson - Piper Sandler Gene Mannheimer - Freedom Capital Markets Allen Lutz - Bank of America Bill Sutherland - Benchmark Stan Berenshteyn - Wells Fargo Matt Hewitt - Craig-Hallum Capital David Larsen - BTIG Operator Good morning, my name is Carly and I will be your conference operator today. At this time, I would like to welcome everyone to the Omnicell First Quarter 2025 Financial Results Conference Call. seekingalpha.com 2025-05-06 16:28:13 Czytaj oryginał (ang.)
Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates Omnicell (OMCL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.03 per share a year ago. zacks.com 2025-05-06 12:40:46 Czytaj oryginał (ang.)
Omnicell Announces First Quarter 2025 Results FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2025 Results. businesswire.com 2025-05-06 10:30:00 Czytaj oryginał (ang.)
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2025-04-28 14:46:31 Czytaj oryginał (ang.)
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? OMCL stays on investors' radar due to the strong performance of the SaaS and Expert Services portfolio. zacks.com 2025-04-22 12:30:39 Czytaj oryginał (ang.)
Here's Why Omnicell (OMCL) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2025-04-10 14:40:48 Czytaj oryginał (ang.)
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2025-03-25 12:40:45 Czytaj oryginał (ang.)
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer. businesswire.com 2025-03-24 18:01:00 Czytaj oryginał (ang.)
Omnicell Gains 41.6% in a Year: What's Driving the Stock? OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning. zacks.com 2025-03-05 11:40:45 Czytaj oryginał (ang.)
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? OMCL stays on investors' radar due to its impressive long-term growth initiative. zacks.com 2025-02-28 12:40:40 Czytaj oryginał (ang.)
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock? Omnicell (OMCL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com 2025-02-24 15:05:38 Czytaj oryginał (ang.)
Omnicell Q4 Earnings: Ignore The Short-Term Noise Omnicell's Q4 2024 earnings showed strong service revenue growth, despite soft overall revenue guidance, highlighting the service business as the key value driver. My updated DCF analysis yields a price target of $64.05, representing a 54% upside, and I raise my rating from buy to strong buy. The service business has grown from 6% to 22% of revenue since 2020, outpacing industry growth and improving margins, indicating long-term value. seekingalpha.com 2025-02-12 09:44:43 Czytaj oryginał (ang.)
Wall Street Analysts Think Omnicell (OMCL) Could Surge 29.03%: Read This Before Placing a Bet The average of price targets set by Wall Street analysts indicates a potential upside of 29% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com 2025-02-11 12:56:13 Czytaj oryginał (ang.)
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises OMCL returns to year-over-year revenue growth in the fourth quarter of 2024. zacks.com 2025-02-10 10:31:15 Czytaj oryginał (ang.)
Omnicell, Inc. (OMCL) Q4 2024 Earnings Call Transcript Omnicell, Inc. (NASDAQ:OMCL ) Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President, Investor Relations Randall Lipps - Founder, Chairman, President and Chief Executive Officer Nchacha Etta - Executive Vice President and Chief Financial Officer Conference Call Participants Allen Lutz - Bank of America Jessica Datson - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Scott Schoenhaus - KeyBanc Capital Markets Stan Berenshteyn - Wells Fargo David Larsen - BTIG Gene Mannheimer - Freedom Capital Markets Operator Thank you for standing by. My name is Kathleen and I will be your conference operator today. seekingalpha.com 2025-02-06 15:24:56 Czytaj oryginał (ang.)
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates Omnicell (OMCL) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.33 per share a year ago. zacks.com 2025-02-06 10:45:41 Czytaj oryginał (ang.)
Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results. businesswire.com 2025-02-06 08:30:00 Czytaj oryginał (ang.)
Is Omnicell Stock a Solid Pick for Your Portfolio Right Now? OMCL stays on investors' radar due to the strong performance of the Advanced Services portfolio. zacks.com 2025-01-31 13:21:08 Czytaj oryginał (ang.)
Omnicell (OMCL) Reports Next Week: Wall Street Expects Earnings Growth Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-01-30 13:07:40 Czytaj oryginał (ang.)
Zacks Industry Outlook Enovis, Omnicell and Phreesia Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article. zacks.com 2025-01-24 04:51:10 Czytaj oryginał (ang.)
3 Medical Info Systems Stocks to Buy as Stargate AI Drives Industry Prospects Zacks Medical Info Systems industry stocks like Enovis, Omnicell and Phreesia are expected to gain from the GenAI wave. zacks.com 2025-01-23 14:21:13 Czytaj oryginał (ang.)
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog. zacks.com 2025-01-23 06:45:27 Czytaj oryginał (ang.)
4 MedTech Stocks Poised to Thrive Under Second Trump Presidency Four MedTech stocks that are set to benefit from Trump 2.0 are DOCS, OMCL, EMBC and COR. zacks.com 2025-01-22 14:56:10 Czytaj oryginał (ang.)
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025 FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025. businesswire.com 2025-01-13 19:47:00 Czytaj oryginał (ang.)
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference. businesswire.com 2025-01-08 18:01:00 Czytaj oryginał (ang.)
Omnicell Gains 26.2% in a Year: What's Driving the Stock? OMCL's shares rise on the back of its XT Amplify program gaining market traction with its initial offerings. However, the unfavorable macroeconomic scenario is concerning. zacks.com 2025-01-06 10:51:20 Czytaj oryginał (ang.)
4 Healthcare Technology Innovators to Invest in Before the New Year Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT. zacks.com 2024-12-19 14:00:40 Czytaj oryginał (ang.)
Why Omnicell (OMCL) Might be Well Poised for a Surge Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. zacks.com 2024-12-18 15:21:09 Czytaj oryginał (ang.)
New Strong Buy Stocks for December 18th LTM, OMCL, DXPE, ALL and CRS have been added to the Zacks Rank #1 (Strong Buy) List on December 18, 2024. zacks.com 2024-12-18 09:00:26 Czytaj oryginał (ang.)
What Makes Omnicell (OMCL) a New Strong Buy Stock Omnicell (OMCL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com 2024-12-12 15:01:19 Czytaj oryginał (ang.)
Best Momentum Stocks to Buy for December 12th ZIM, OMCL and FOA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 12, 2024. zacks.com 2024-12-12 13:16:11 Czytaj oryginał (ang.)
Omnicell Introduces OmniSphere Platform, Stock to Gain Omnicell introduces OmniSphere. Additionally, the company showcases a full portfolio of outcomes-centric solutions at the ASHP Midyear 2024. zacks.com 2024-12-12 11:41:08 Czytaj oryginał (ang.)
New Strong Buy Stocks for December 12th NBBK, OMCL, ZIM, IMCR and ULS have been added to the Zacks Rank #1 (Strong Buy) List on December 12, 2024. zacks.com 2024-12-12 09:21:22 Czytaj oryginał (ang.)
Omnicell Announces OmniSphere FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces OmniSphere; Next-generation, cloud native, software workflow engine will integrate Omnicell solutions across care settings. businesswire.com 2024-12-09 10:30:00 Czytaj oryginał (ang.)
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025 Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV. zacks.com 2024-12-04 11:01:30 Czytaj oryginał (ang.)
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report? Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock? zacks.com 2024-11-29 14:36:56 Czytaj oryginał (ang.)
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference. businesswire.com 2024-11-22 18:01:00 Czytaj oryginał (ang.)
Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here's is How to Trade The mean of analysts' price targets for Omnicell (OMCL) points to a 26.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com 2024-11-21 12:56:13 Czytaj oryginał (ang.)
Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering. businesswire.com 2024-11-20 04:00:00 Czytaj oryginał (ang.)
Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes. businesswire.com 2024-11-18 18:12:00 Czytaj oryginał (ang.)
Here's Why You Should Add OMCL Stock to Your Portfolio Now A robust Advanced Services portfolio and long-term growth initiatives bode well for Omnicell. zacks.com 2024-11-18 10:45:20 Czytaj oryginał (ang.)
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. zacks.com 2024-11-06 15:20:22 Czytaj oryginał (ang.)
Omnicell Q3 Earnings: Look At The Growth Segment Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a strong and growing service business. Omnicell has unique technology with strong market tailwinds that support long-term growth. seekingalpha.com 2024-11-01 13:58:31 Czytaj oryginał (ang.)
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised Omnicell continues its trend of impressive results in the third quarter of 2024. zacks.com 2024-10-31 15:51:10 Czytaj oryginał (ang.)
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out? Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2024-10-31 12:15:42 Czytaj oryginał (ang.)
Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript Omnicell, Inc. (NASDAQ:OMCL ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Kathleen Neiman - Senior Vice President, Investor Relations Randall Lipps - Founder, Chairman, President & Chief Executive Officer Nchacha Etta - Executive Vice President & Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Jessica Tassan - Piper Sandler Allen Lutz - Bank of America Stephanie Davis - Barclays Anne Samuel - JPMorgan Scott Schoenhaus - KeyBanc Capital Markets Bill Sutherland - The Benchmark Company Stan Berenshteyn - Wells Fargo David Larsen - BTIG Operator Thank you for standing by. My name is John, and I'll be your conference operator today. seekingalpha.com 2024-10-30 16:07:05 Czytaj oryginał (ang.)